Casdatifan (AB521) is a novel and potent allosteric small molecule inhibitor of protumourigenic HIF‐2α dependent transcription.
Saved in:
| Title: | Casdatifan (AB521) is a novel and potent allosteric small molecule inhibitor of protumourigenic HIF‐2α dependent transcription. |
|---|---|
| Authors: | Schweickert, Patrick G.1 (AUTHOR), Piovesan, Dana1 (AUTHOR), Mitchell, Casey G.1 (AUTHOR), Zepeda‐Carranza, Bryan1 (AUTHOR), Zhu, Wandi S.1 (AUTHOR), Lopez Espinoza, Alejandra Y.1 (AUTHOR), Rocha, Lauren1 (AUTHOR), Singh, Jaskirat1 (AUTHOR), Malgapo, Martin Ian P.1 (AUTHOR), Meleza, Cesar1 (AUTHOR), Northington, Kyle R.1 (AUTHOR), Ray, Rebecca D.1 (AUTHOR), Zhao, Xiaoning1 (AUTHOR), Lawson, Kenneth V.1 (AUTHOR), Walters, Matthew J.1 (AUTHOR), Sivick, Kelsey E.1 (AUTHOR) ksivick@arcusbio.com |
| Source: | British Journal of Pharmacology. Sep2025, Vol. 182 Issue 17, p4147-4167. 21p. |
| Database: | Academic Search Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 00071188 |
|---|---|
| DOI: | 10.1111/bph.70075 |